Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of Dapagliflozin on Lipoprotein Kinetics in Patients With Type 2 Diabetes

NCT03269058 is registered in ClinicalTrials.gov with Centre Hospitalier Universitaire Dijon as lead sponsor.

NCT NCT03269058
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03269058 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of Dapagliflozin on Lipoprotein Kinetics in Patients With Type 2 Diabetes
Lead sponsor
Centre Hospitalier Universitaire Dijon
Phase
Phase 4
Overall status
Completed
Start date
December 20, 2017
Completion date
May 6, 2021
Enrollment
28 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

oral antidiabetics, type-2 diabetes